Scinai Immunotherapeutics Ltd - ADR (2F5): aksiya narxi va yangiliklar

Belgilar Belgilar	Narxi	Oʻzgartirishlar	Dinamika (%)	Trend	Avvalgi yopilish narxi	Ochish	Yuqori	Past	Hajmi	Bozor kapitali
SIXB Materials SIXB Materials	SIXB -0,32%	1 100,57	-3,53	-0,32%	—	1 104,10	1 103,92	1 108,75	1 097,16	—	—
SIXC Communications SIXC Communications	SIXC +0,16%	605,15	+0,99	+0,16%	—	604,16	604,16	610,19	604,12	—	—
SIXE Energy SIXE Energy	SIXE -0,22%	1 195,19	-2,62	-0,22%	—	1 197,81	1 200,58	1 213,07	1 192,02	—	—
SIXI Industrials SIXI Industrials	SIXI -0,03%	1 739,91	-0,50	-0,03%	—	1 740,41	1 739,55	1 750,27	1 730,60	—	—
SIXM Financials SIXM Financials	SIXM +0,65%	638,56	+4,12	+0,65%	—	634,44	633,13	639,87	633,01	—	—
SIXR Staples SIXR Staples	SIXR -1,11%	831,57	-9,33	-1,11%	—	840,90	839,53	841,73	831,10	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0,82%	213,36	-1,77	-0,82%	—	215,13	215,13	215,85	213,24	—	—
SIXT Technology SIXT Technology	SIXT +0,17%	3 234,18	+5,47	+0,17%	—	3 228,71	3 225,62	3 235,43	3 198,95	—	—
SIXU Utilities SIXU Utilities	SIXU -0,02%	935,65	-0,22	-0,02%	—	935,87	938,37	942,00	935,65	—	—
SIXV Health care SIXV Health care	SIXV -0,54%	1 449,26	-7,86	-0,54%	—	1 457,12	1 452,74	1 466,88	1 449,18	—	—
SIXY Discretionary SIXY Discretionary	SIXY -0,72%	2 382,45	-17,39	-0,72%	—	2 399,84	2 389,71	2 394,61	2 371,22	—	—

2F5:FRA

Scinai Immunotherapeutics Ltd - ADR

0,56 €

0,00%

(0,00) 1K

27-apr, 15:25:01 (GMT+2) · EUR

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

2F5 tikeri uchun statistika yaratilmoqda...

Bozor kapitali

2,11 mln

Oʻrtacha hajm

4,00

Hajmi

0,00

52 haftalik eng yuqori

4,98 €

52 haftalik eng past

0,38 €

Xodimlar soni

Yangiliklar

Internetdagi manbalardan

TipRanks

10 soat oldin

Scinai Immunotherapeutics Raises $2.61 Million in ADS and Warrant Financing to Expand CDMO and Immunotherapy Programs

Stock Titan

11 soat oldin

Scinai Immunotherapeutics (NASDAQ: SCNI) closes $2.61M ADS and warrant financing

www.marketscreener.com

20 soat oldin

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Quiver Quantitative

3 kun oldin

Scinai Immunotherapeutics jumps on $2.61M private placement financing

Profil

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia

Scinai Immunotherapeutics Ltd - ADR haqida

CEO-

Xodimlar soni45

Asos solingan1-yan, 2003

Bosh ofislar-

Sektor-

Veb-saytscinai.com

Barcha qiymatlar – USD	mar, 2025	iyn, 2025	sen, 2025	dek, 2025
Daromad	386,50 ming	386,50 ming	269,00 ming	269,00 ming
Sotilgan mahsulotning tannarxi	1,02 mln	1,02 mln	960,00 ming	960,00 ming
Daromad narxi	1,02 mln	1,02 mln	960,00 ming	960,00 ming
Tadqiqot va ishlanmalarga xarajatlar	618,50 ming	618,50 ming	566,00 ming	566,00 ming
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	628,00 ming	628,00 ming	632,50 ming	632,50 ming
Operatsion xarajatlar	1,25 mln	1,25 mln	1,20 mln	1,20 mln
Jami operatsion xarajatlar	2,27 mln	2,27 mln	2,16 mln	2,16 mln
Operatsion daromad	-1,88 mln	-1,88 mln	-1,89 mln	-1,89 mln
Boshqa nooperatsion daromad	-	-	-3,50 ming	-3,50 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	-2,07 mln	-2,07 mln	-2,09 mln	-2,09 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	-2,07 mln	-2,07 mln	-2,09 mln	-2,09 mln
Daromad soligʻi boʻyicha xarajat	-	-	-	-
Amaldagi soliq stavkasi	-	-	-	-
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	-2,07 mln	-2,07 mln	-2,09 mln	-2,09 mln
Sof foyda marjasi	-534,80%	-534,80%	-775,65%	-775,65%
Har bir aksiya foydasi	-	-	-	-
Foizlar va investitsiyalardan olingan daromadlar	-	-	16,00 ming	16,00 ming
Foizlarni toʻlash xarajatlari	-185,50 ming	-185,50 ming	-	-
Foizlarni toʻlash boʻyicha sof xarajatlar	-185,50 ming	-185,50 ming	16,00 ming	16,00 ming
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	-1,53 mln	-1,53 mln	-1,53 mln	-1,53 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	-	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil